Participated · Series C · Sep 2024

Vesta Healthcare operates a virtual care platform that connects patients, family, caregivers, home care agencies, providers, and insurance plans to improve care in the home. Its technology and services span from home-based primary care to passive monitoring and caregiver-enabled clinical workflows. Vesta positions caregivers as an integrated part of the clinical care team to improve outcomes for people with home care needs. The company says it is one of the fastest-growing specialized providers and now serves more than 50,000 people. Vesta recently closed a financing round (Series C) and secured additional debt financing to propel growth. The funding is intended to support continued expansion of its technology and services in the home-care setting. Vesta Healthcare operates a 24/7 clinical provider group and digital health platform centered on its "Homecareist" model, which coordinates in‑home care between patients, paid and unpaid caregivers, and the broader care team. The company delivers telehealth, virtual chronic care management, and remote health monitoring to high‑need, frail senior populations through partnerships with home care agencies, health plans, and providers. Vesta reports that 88% of urgent alerts can be managed and resolved in the home and that its program has driven over a 30% reduction in emergency room visits and hospital admissions. Founded in 2018 and headquartered in New York, Vesta now has a presence in five states and nearly nationwide coverage through its affiliated medical group. The company plans to expand into new geographies, launch new program offerings, broaden partnerships with home care agencies, and take on population health programs and financial risk contracts. The new financing will also fund expansion of Sales, Marketing, Operations, and Technology teams to scale its technology‑enabled caregiver engagement and in‑home clinical programs. Vesta Healthcare (fka HT Health) provides technology and clinical services to support caregivers and link caregiver insights to the rest of the care team. The company proactively identifies needs for additional resources in the home and offers 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to build value-based population health programs emphasizing clinical quality, improved outcomes and personalized engagement. The company is led by CEO Randy Klein and is based in New York City. Vesta closed a $30M Series A to fund growth and plans to use the capital to expand product development, engineering, sales and marketing and to reach new markets.

Participated · Series B · Dec 2022

BehaVR, formed by the merger of Nashville-based BehaVR and OxfordVR, builds evidence-based immersive digital therapeutics delivered on an integrated platform. The combined company will operate under the BehaVR brand and is led by CEO Aaron Gani. Its suite of clinically validated therapeutics spans mental wellness and mental and behavioral conditions, including validated treatments for serious mental illness. The platform simplifies the patient experience, enables clinician oversight, and generates patient-specific care plans and measurable outcomes. OxfordVR's gameChange product has been granted FDA Breakthrough Device designation and will deliver automated cognitive-behavioral VR therapy that can be administered by clinical staff, peer group members, or at home.

Participated · Series B · Mar 2022

Embold Health provides real-time, transparent and actionable data on provider quality using practice-pattern and appropriateness metrics for employers, employees, health plans and health systems. Its physician-led analytics platform aligns cost and performance data with clinical guidelines across specialties including cardiology, endocrinology, gastroenterology, obstetrics, ortho-joint, pediatrics, primary care, pulmonology and spine. The tools help connect patients with top-performing providers and support engagement among physician groups, health systems, plans and employers to enable value-based care. Embold emphasizes objective, consumer-facing physician performance metrics and presents data intended to drive continuous improvement among all physicians. In a research partnership with Harvard Medical School, Embold analyzed nearly 9,000 doctors across five metropolitan areas and identified wide variations in care decisions, finding higher-performing specialists more often chose appropriate, evidence-based care. The company is using its recent financing to support national expansion and broader adoption of its quality-measurement services.

Participated · Series B · Jul 2021

Swift Medical builds AI-driven digital wound care tools and an imaging app used to standardize assessment, documentation, and remote care across the continuum of care. Core product offerings highlighted in the announcement include SmartTissue™, AutoDepth™ and HealingIndex™, which aim to improve wound evaluations, reduce treatment variability and identify risk more accurately. The company reports being the trusted wound care technology partner of more than 4,000 healthcare facilities in North America with over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, which underpin its clinical analytics and remote-care capabilities. Swift says its technology is associated with 37% faster wound healing and a 39% increase in measurement accuracy on darker skin tones in cited studies. Headquartered in Toronto, Swift operates across the U.S. and Canada and is pursuing broader commercialization and deployment of its AI tools. Swift Medical provides an AI-driven digital wound care platform that offers high-precision imaging, compliant documentation, clinical analytics, and remote care. The company serves more than 4,000 healthcare facilities across North America and has over 20,000 clinical users. Its platform has captured more than 20 million wound images and 40 million assessments, supporting standardized and equitable wound care. Headquartered in Toronto, Swift is expanding operations across the U.S. and Canada. The company plans significant platform enhancements in 2024, including enhanced data security, improved interoperability, and enhanced device capabilities. The recent financing is intended to accelerate those technology improvements and expand the company’s reach. Swift Medical offers an AI-powered digital wound care platform that lets patients and clinicians capture high-precision wound images with a mobile phone, autonomously determine wound dimensions and clinical characteristics, enable virtual wound consultations, and provide real-time predictive insights. The technology is used by over 4,000 healthcare organizations across all 50 states and spans the full continuum of care. The company says it has grown 300% year-over-year in every new market it has entered over the past three years. Swift Medical positions itself as the dominant market player in digital wound management and emphasizes improving prevention, treatment, and management of wounds. With the new funding, the company plans to expand its market position and scale its platform across the care continuum in North America and continue growing its team. The stated mission is to prevent wounds before they occur and improve quality of care for every patient with a wound. Swift Medical offers an enterprise-grade, smartphone-ready Swift Skin and Wound software that delivers advanced wound visualization and touchless 3D measurement without touching the wound or requiring extra equipment. The platform captures images and measurements including wound depth, provides automatic risk scoring, schedules assessments, and supports claims submission to streamline clinical and administrative wound care workflows. Swift has been adopted by over 1,000 healthcare facilities managing more than 100,000 beds and reports helping heal over 10,000 patients a month. The company has partnerships with PointClickCare and Healogics and positions itself as a global market leader and enterprise solutions partner in digital wound care management. Management says the Series A funding will be used to expand reach and bring Swift’s solution to every bedside in hospitals and care facilities. Swift frames its mission around digitizing wound care management to augment clinician capabilities and address the global burden of chronic wounds.

Participated · Equity · Apr 2021

Votive Health is a technology-enabled network manager delivering complex care at home for people with serious illness. The company combines value-based care models with a technology platform that facilitates payer-provider integration through value-based arrangements. Led by founder and CEO Torrie Fields and based in San Luis Obispo, CA, Votive's leadership includes clinical, legal, finance, technology, and network strategy executives. On April 28, 2021 Votive raised $2.5M in funding to support its growth. The company intends to use the proceeds to accelerate and scale its operations. Board changes accompanying the raise included new directors and an observer from major participating investors.